Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I–associated myelopathy

References

• Aye M M, Matsuoka E, Moritoyo T, Umehara F, Suehara M, Hokezu Y, Yamanaka H, Isashiki Y, Osame M, Izumo S. Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system. Acta Neuropathol (Berl) 2000; 100: 245–252
   PubMed Web of Science ®Google Scholar
• Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M, Osame M. Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2000; 182: 1343–1349
   PubMed Web of Science ®Google Scholar
• Gessain A, Barin F, Vernant J C, Gout O, Maurs L, Calender A, de The G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; 2: 407–410
   PubMed Web of Science ®Google Scholar
• Iwasaki Y. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 1990; 96: 103–123
   Google Scholar
• Iwasaki Y, Ohara Y, Kobayashi I, Akizuki S. Infiltration of helper/inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection. Am J Pathol 1992; 140: 1003–1008
   PubMed Web of Science ®Google Scholar
• Jeffery K J, Siddiqui A A, Bunce M, Lloyd A L, Vine A M, Witkover A D, Izumo S, Usuku K, Welsh K I, Osame M, Bangham C R. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J Immunol 2000; 165: 7278–7284
   PubMed Web of Science ®Google Scholar
• Jeffery K J, Usuku K, Hall S E, Matsumoto W, Taylor G P, Procter J, Bunce M, Ogg G S, Welsh K I, Weber J N, Lloyd A L, Nowak M A, Nagai M, Kodama D, Izumo S, Osame M, Bangham C R. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci U S A 1999; 96: 3848–3853
   PubMed Web of Science ®Google Scholar
• Levin M C, Lehky T J, Flerlage A N, Katz D, Kingma D W, Jaffe E S, Heiss J D, Patronas N, McFarland H F, Jacobson S. Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease. New Engl J Med 1997; 336: 839–844
   PubMedGoogle Scholar
• Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham C R, Izumo S, Osame M. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J NeuroVirol 1998; 4: 586–593
   PubMed Web of Science ®Google Scholar
• Nose H, Saito M, Usuku K, Sabouri A H, Matsuzaki T, Kubota R, Eiraku N, Furukawa Y, Izumo S, Arimura K, Osame M. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age and provirus load. J NeuroVirol 2006; 12: 171–177
   PubMed Web of Science ®Google Scholar
• Osame M. Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. Human Retrovirology: HTLV, W A Blattner. Raven Press, New York 1990; 191–197
   Google Scholar
• Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1: 1031–1032
   PubMed Web of Science ®Google Scholar
• Umehara F, Osame M. Histological analysis of HAM/TSP pathogenesis. Two decades of adult T-cell leukemia and HTLV-I research, K Sugamura, T Uchiyama, M Masao, M Kannagi. Japan Scientific Societies Press, Tokyo 2003; 141–148
   Google Scholar
• Shakudo M, Inoue Y, Tukada T. HTLV-I-associated myelopathy: acute progression and atypical MR findings. Am J Neuroradiol 1999; 20: 1417–1421
   Google Scholar
• Tajima Y, Kishimoto R, Sudoh K, Miyazaki Y, Kikuchi S, Tashiro K. Spinal magnetic resonance image alterations in human T-lymphotropic virus type I-associated myelopathy patients before and after immunomodulating treatment. J Neurol 2003; 250: 750–753
   Google Scholar
• Umehara F, Izumo S, Nakagawa M, Ronquillo A T, Takahashi K, Matsumuro K, Sato E, Osame M. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I associated myelopathy. J Neuropathol Exp Neurol 1993; 52: 424–430
   Google Scholar
• Umehara F, Nagatomo S, Yoshishige K, Saito M, Furukawa Y, Usuku K, Osame M. Chronic progressive cervical myelopathy with HTLV-I infection: variant form of HAM/TSP?. Neurology 2004; 63: 1276–1280
   Google Scholar
• Umehara F, Tokunaga N, Hokezu Y, Hokonohara E, Yoshishige K, Shiraishi T, Okubo R, Osame M. Relapsing cervical cord lesions on MRI in patients with HTLV-I-associated myelopathy. Neurology 2006; 66: 289
   Google Scholar
• Vine A M, Witkover A D, Lloyd A L, Jeffery K J, Siddiqui A, Marshall S E, Bunce M, Eiraku N, Izumo S, Usuku K, Osame M, Bangham C R. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2002; 186: 932–939
   PubMed Web of Science ®Google Scholar
• Watanabe M, Yamashita T, Hara A, Murakami T, Ando Y, Uyama E, Mita S, Uchino M. High signal intensity in the spinal cord on T2-weighted images in rapidly progressive tropical spastic paresis. Neuroradiology 2001; 43: 231–233
   Google Scholar